NCT03216980View on ClinicalTrials.gov

Examining the Effect of Mental Health Disorders on Vascular Function and Exercise Tolerance

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 15, 2017

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions
Mental Health Disorders
Interventions
DIETARY_SUPPLEMENT

PTSD/GAD Antioxidant

Subjects will ingest an antioxidant cocktail containing 800 milligrams of alpha lipoic acid, 1 gram of vitamin C (ascorbic acid), and 400 milligrams of vitamin E (alpha tocopherol).

DIETARY_SUPPLEMENT

PTSD/GAD Placebo

Subjects will ingest placebo (microcrystalline cellulose) pills.

DIETARY_SUPPLEMENT

Healthy Control Antioxidant

Subjects will ingest an antioxidant cocktail containing 800 milligrams of alpha lipoic acid, 1 gram of vitamin C (ascorbic acid), and 400 milligrams of vitamin E (alpha tocopherol).

DIETARY_SUPPLEMENT

Healthy Control Placebo

Subjects will ingest placebo (microcrystalline cellulose) pills.

Trial Locations (1)

23298

Virginia Commonwealth University, Richmond

All Listed Sponsors
lead

Virginia Commonwealth University

OTHER

NCT03216980 - Examining the Effect of Mental Health Disorders on Vascular Function and Exercise Tolerance | Biotech Hunter | Biotech Hunter